Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA2B4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,214
Award facts
- Contract value 100% obligated
- $16,213.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,213.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections on January 12, 2026, with completion scheduled for January 13, 2026. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 2031 that serves as the primary procurement mechanism for pharmaceutical and medical supply distribution to military healthcare systems worldwide.
AmerisourceBergen functions as a critical pharmaceutical distributor within the federal medical supply chain, delivering a comprehensive portfolio of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to support Defense Health Agency operations and broader military healthcare requirements. The DLA Troop Support Medical IDC under which this delivery order is executed encompasses pharmaceutical commodities across multiple therapeutic domains, enabling efficient fulfillment of government medical procurement needs. Cencora's contract awards demonstrate its sustained competitive capability to meet federal pharmaceutical procurement requirements through open competition without set-aside restrictions.
Quick answers
Who was awarded contract SPE2DR26FA2B4?
SPE2DR26FA2B4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FA2B4 worth?
The government has obligated $16,214 on SPE2DR26FA2B4.
Is contract SPE2DR26FA2B4 an order under another contract?
Yes. SPE2DR26FA2B4 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2B4 competed?
The extent of competition for SPE2DR26FA2B4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award